Conference Coverage: ASCO 2023 – Focus on Breast Cancer

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making coming out of the ASCO 2023 conference.

June 13, 2023


Adam Brufsky, MD, PhD, FACP

Magee-Womens Cancer Program at the UPMC Hillman Cancer Center, Pittsburgh, PA, USA


Joseph Gligorov, MD, PhD
AP-HP Tenon, Paris, France

Guy H. Jerusalem, MD, PhD
University of Liège/CHU de Liège, Belgium

Giuseppe Curigliano, MD, PhD
University of Milano, Italy

Nadia Harbeck, MD, PhD
Ludwig Maximilian University of Munich, Germany

Joyce O’Shaughnessy, MD
Baylor University Medical Center, Dallas, TX, USA

Peter A. Kaufman, MD
The University of Vermont Medical Center, Burlington, VT, USA

Mark Pegram, MD
Stanford University School of Medicine, Stanford, CA, USA

Sara Tolaney, MD, MPH
Dana-Farber Cancer Institute, Boston, MA, USA



Download the meeting agenda

View Agenda

Sample Report

Start discovering the insights

View Report


  • Updates on Neoadjuvant Therapies for Breast Cancer
  • CDK4/6 Inhibitors in the Treatment of HR+, HER2– Breast Cancer
  • Novel Therapeutic Approaches for HR+, HER2– Breast Cancer
  • Evolving Treatments for HER2+, HER2–, and HER2-Low Breast Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.